MX9203197A - Prodrogas de esteres que contienen sulfonato de corticisteroides. - Google Patents

Prodrogas de esteres que contienen sulfonato de corticisteroides.

Info

Publication number
MX9203197A
MX9203197A MX9203197A MX9203197A MX9203197A MX 9203197 A MX9203197 A MX 9203197A MX 9203197 A MX9203197 A MX 9203197A MX 9203197 A MX9203197 A MX 9203197A MX 9203197 A MX9203197 A MX 9203197A
Authority
MX
Mexico
Prior art keywords
prodroges
corticisteroid
sulphonate
esters containing
esters
Prior art date
Application number
MX9203197A
Other languages
English (en)
Spanish (es)
Inventor
Bradley D Anderson
Robert A Conradi
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of MX9203197A publication Critical patent/MX9203197A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX9203197A 1983-01-21 1992-06-26 Prodrogas de esteres que contienen sulfonato de corticisteroides. MX9203197A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/459,742 US4472392A (en) 1983-01-21 1983-01-21 Sulfonate containing ester prodrugs of corticosteroids

Publications (1)

Publication Number Publication Date
MX9203197A true MX9203197A (es) 1992-09-01

Family

ID=23825979

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203197A MX9203197A (es) 1983-01-21 1992-06-26 Prodrogas de esteres que contienen sulfonato de corticisteroides.

Country Status (8)

Country Link
US (1) US4472392A (enExample)
EP (1) EP0120557B1 (enExample)
JP (1) JPS59137500A (enExample)
CA (1) CA1199908A (enExample)
DE (1) DE3478605D1 (enExample)
HK (1) HK43993A (enExample)
MX (1) MX9203197A (enExample)
ZA (1) ZA838826B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588718A (en) * 1984-03-28 1986-05-13 The Upjohn Company Carboxy containing ester prodrugs of corticosteroids
CA1310009C (en) * 1984-03-28 1992-11-10 John Mark Braughler Ester prodrugs of steroids
US5446177A (en) * 1984-12-28 1995-08-29 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
US4686214A (en) * 1985-10-30 1987-08-11 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
AU2138988A (en) * 1987-07-16 1989-02-13 Upjohn Company, The Amine salts of alkane-1,n-dicarboxylic acid mono- (2-sulfato-ethyl)amides
BR9307746A (pt) * 1993-01-08 1995-11-14 Astra Ab Derivados de esteróides especificos para otratamento de cólon e ileo
US5420120A (en) * 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
EP1562627A4 (en) * 2002-08-23 2006-11-02 Mclean Hospital Corp CORTICOSTEROID CONJUGATES AND ITS USES
EP1663999A2 (en) * 2003-08-29 2006-06-07 Ranbaxy Laboratories, Ltd. Inhibitors of phosphodiesterase type-iv
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
AU2006305619A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
EP1948167A1 (en) * 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Compositions of phosphodiesterase type iv inhibitors
MX2009003100A (es) * 2006-09-22 2009-05-11 Ranbaxy Lab Ltd Inhibidores de fosfodiesterasa tipo iv.
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
JP5607930B2 (ja) 2006-10-12 2014-10-15 ビーエイチアイ リミテッド パートナーシップ 3−アミノ−1−プロパンスルホン酸を送達するための方法、化合物、組成物および媒体
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
AU2008224541B2 (en) 2007-03-14 2013-08-22 Sun Pharmaceutical Industries Limited Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
WO2008111009A1 (en) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
US20090306579A1 (en) 2008-02-25 2009-12-10 Eyegate Pharmaceuticals, Inc. Delivery of corticosteroids through iontophoresis
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
WO2022037704A1 (zh) * 2020-08-21 2022-02-24 诺茗(北京)生物医药有限公司 一种水溶性抗肿瘤前药及其药物组合物和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3089881A (en) * 1957-10-29 1963-05-14 Schering Corp Sulfocarboxylic acid esters of hydroxylated steroids
US2986559A (en) * 1959-01-07 1961-05-30 Schering Corp Novel therapeutic salts and processes for their manufacture
US3171846A (en) * 1962-07-10 1965-03-02 Erba Carlo Spa Prednisolone-21-double esters
NL124139C (enExample) * 1964-11-04
FR6590M (enExample) * 1967-10-31 1968-12-30
US3609712A (en) * 1969-01-15 1971-09-28 Ibm Insulated gate field effect transistor memory array
US4221787A (en) * 1978-03-28 1980-09-09 Interx Research Corporation Esteramide prodrugs of anti-inflammatory corticosteroids
SU818489A3 (ru) * 1978-10-04 1981-03-30 Шеринг Аг (Фирма) Способ получени кортикоид -21- СульфОпРОпиОНАТОВ или иХ СОлЕй
DE2848423A1 (de) * 1978-11-08 1980-05-29 Merck Patent Gmbh Hydrocortisonester, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
US4472392A (en) 1984-09-18
DE3478605D1 (en) 1989-07-13
JPH0226639B2 (enExample) 1990-06-12
EP0120557A3 (en) 1985-02-06
HK43993A (en) 1993-05-14
ZA838826B (en) 1984-07-25
EP0120557A2 (en) 1984-10-03
JPS59137500A (ja) 1984-08-07
EP0120557B1 (en) 1989-06-07
CA1199908A (en) 1986-01-28

Similar Documents

Publication Publication Date Title
MX9203197A (es) Prodrogas de esteres que contienen sulfonato de corticisteroides.
ES288754Y (es) Disposicion de apertura de recipientes.
DK462884A (da) Vaegelement
BR8101839A (pt) Conjunto de silencioso
DK423482A (da) Laserinstrument
BR8306394A (pt) Instrumento de escrever
FR2543111B1 (fr) Boite
ES292404Y (es) Cierre de adorno.
FR2567606B1 (fr) Boite de vitesses mecanique-hydrostatique synchronisee
DK277785D0 (da) Vaegelement
FI840138A0 (fi) Detergentblandning i partikelform
DE3567866D1 (de) Liquid thioxanthoncarboxilic-acid esters
TR20994A (tr) Gizli
DE3471479D1 (de) Substituted phenoxyalcanoic-acid ester
FR2563187B1 (fr) Boite combinee
DK445584D0 (da) Vaegelement
SE8405517D0 (sv) Prefabricerad skivvegg
FR2546032B1 (fr) Caisse de forcage
KR840004776U (ko) 방향제 용기
ES272052Y (es) Conjunto de envases separables.
FR2554316B1 (fr) Variete de potentille
SE8304328D0 (sv) Eldflugan
BR8303729A (pt) Processadora de microfichas
LT2079B (lt) Tetrahidroftalimidiniu junginiu gavimo budas
BR8303826A (pt) Casas de inflar